ALTON SARTOR, M.D.
Medical Oncology Physician · ROCHESTER, MN
Individual Active NPI 1801877501
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 311 | 48,916 | $4,140,936 | $1,346,333 | $1,072,029 |
| 2023 | 223 | 7,855 | $901,639 | $294,119 | $232,681 |
| 2022 | 296 | 686 | $147,058 | $52,850 | $41,321 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 5,802 | $53 | $42 |
| J1453 | Injection, fosaprepitant, 1 mg | 5,400 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 3,423 | $49 | $39 |
| J9267 | Injection, paclitaxel, 1 mg | 2,962 | $0 | $0 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 650 | $1 | $1 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 596 | $0 | $0 |
| J9041 | Injection, bortezomib, 0.1 mg | 585 | $2 | $1 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 412 | $0 | $0 |
| 96375 | Injection of additional new drug or substance into vein | 232 | $15 | $12 |
| J9206 | Injection, irinotecan, 20 mg | 188 | $2 | $2 |
| J9190 | Injection, fluorouracil, 500 mg | 175 | $3 | $2 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 162 | $125 | $98 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | 73531 | MN |
| Medical Oncology Physician | 207RX0202X | MD017596 | LA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Minnesota
- NPI 1437278959
- NPI 1003376468
- NPI 1982680583
- NPI 1437136553
- NPI 1417148180
- NPI 1306879028
- NPI 1265729834
- NPI 1609883321
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.